Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
| (NASDAQ: GPCR) | Delayed: 27.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.47 | 52 Week High | $ | |||
| Open | $27.47 | 52 Week Low | $ | |||
| Day High | $27.47 | P/E | N/A | |||
| Day Low | $27.47 | EPS | $ | |||
| Volume | 2,027 | |||||
| VEEVA SYSTEMS, Inc. (NYSE: VEEV) | Delayed: 283.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $283.50 | 52 Week High | $42.58 | |||
| Open | $283.50 | 52 Week Low | $19.97 | |||
| Day High | $283.50 | P/E | 9,450.00 | |||
| Day Low | $283.50 | EPS | $0.03 | |||
| Volume | 2,014 | |||||
